Issue Date | Title | Author(s) |
2014 | Antiplatelet and anticoagulant therapy for non-ST-elevation acute coronary syndromes in a general hospital | Mason, Giorgia; Wirth, Francesca; Cignarella, Andrea; Xuereb, Robert G.; Azzopardi, Lilian M. |
2013-10 | Antiplatelet and anticoagulation treatment for non-ST-elevation acute coronary syndromes | Mason, Giorgia; Wirth, Francesca; Azzopardi, Lilian M.; Xuereb, Robert G.; Cignarella, Andrea |
2019-03 | Assessing medication adherence and condition-related knowledge of heart failure patients | Debono, Ivan; Grech, Louise; Xuereb, Robert G.; Azzopardi, Lilian M. |
2015-06 | Association of the CYP2C19 *2 allele on the occurrence of in-stent restenosis in patients undergoing coronary stenting | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M. |
2010 | Atrial fibrillation : a common arrhythmia with possible dire consequences | Xuereb, Robert G. |
2019-09 | Cardiac rehabilitation and smoking status | Anders, Henry O.; Wirth, Francesca; Gauci, Marilyn; Xuereb, Clifford; Desira, Josette; Xuereb, Robert G.; Azzopardi, Lilian M. |
2020 | Comparative analysis of lipid profile management in ischaemic heart disease | Zarb, Maia; Xuereb, Robert G.; Wirth, Francesca; Azzopardi, Lilian M. |
2015-10 | Comparison between a point-of-care and a laboratory-based CYP2C19*2 genotyping assay for pharmacist-led personalisation of antiplatelet therapy | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M. |
2016 | Comparison of a rapid point-of-care and two laboratory-based CYP2C19*2 genotyping assays for personalisation of antiplatelet therapy | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M. |
1992 | Coronary artery spasm : role in acute myocardial ischaemia | Xuereb, Robert G.; Xuereb, Mariosa |
2019-02 | CYP2C19 genetic polymorphisms in Maltese patients on clopidogrel therapy | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M. |
2021 | CYP2C19* 2 genetic polymorphism and incidence of in-stent restenosis in patients on clopidogrel : a matched case-control study | Osama, Sara; Wirth, Francesca; Zahra, Graziella; Barbara, Christopher; Xuereb, Robert G.; Camilleri, Liberato; Azzopardi, Lilian M. |
2018 | CYP2C19*2 allele carrier status and coronary in-stent restenosis : is there an association? | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Camilleri, Liberato; Fenech, Albert; Azzopardi, Lilian M. |
2020 | CYP2C19*2 genetic polymorphism and other predictors for coronary in-stent restenosis in patients on clopidogrel therapy | Osama, Sara; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Azzopardi, Lilian M. |
2020 | Evaluating the safety and tolerability of sacubitril/valsartan | Vandenbroeke, Helena; Wirth, Francesca; Xuereb, Robert G.; Steurbaut, Stephane; Azzopardi, Lilian M. |
2023-04 | Experience with statin therapy in patients undergoing cardiac procedures | Calleja, Jean Claude; Wirth, Francesca; Xuereb, Robert G.; Azzopardi, Lilian M. |
2016 | Female gender and cardiovascular disease | Xuereb, Rachel; Magri, Caroline J.; Xuereb, Sara; Xuereb, Mariosa; Zammit-Mangion, Marion; Xuereb, Robert G. |
2017-10 | Impact of rivaroxaban in cardiovascular disease | Cardona, Mark; Wirth, Francesca; Serracino-Inglott, Anthony; Xuereb, Robert G.; Azzopardi, Lilian M. |
2003 | The long and winding road: the management of Acute Coronary Syndromes in Malta | Xuereb, Robert G.; Xuereb, Mariosa |
2018-10 | Low density lipoprotein control in patients with ischaemic heart disease | Curtolo, Elisa; Wirth, Francesca; Xuereb, Robert G.; Camilleri, Liberato; Cignarella, Andrea; Azzopardi, Lilian M. |
2014 | Non-dipping heart rate and microalbuminuria in type 2 diabetes mellitus | Magri, Caroline Jane; Xuereb, Robert G.; Fava, Stephen |
2011 | Peroxisome proliferator-activated receptor-γ and the endothelium : implications in cardiovascular disease | Magri, Caroline Jane; Gatt, Noel; Xuereb, Robert G.; Fava, Stephen |
2015-06 | Pharmacist-led CYP2C19 genotyping in patients on clopidogrel therapy following percutaneous coronary intervention | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M. |
2016-03 | Pharmacist-led rapid point-of-care CYP2C19 genotyping for individualisation of antiplatelet therapy | Wirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M. |
2019-03 | Pharmacogenetic testing for personalisation of statin therapy | Cerdá Iñesta, Judith; Wirth, Francesca; Mifsud Buhagiar, Luana; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony |
2015-10 | Point-of-care CYP2C19 genotyping in patients prescribed clopidogrel therapy following a percutaneous coronary intervention | Wirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M. |
2015-09 | Prevalence of the CYP2C19 *2 allele in Maltese patients on clopidogrel therapy | Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Fenech, Albert; Azzopardi, Lilian M. |
2017-01 | Rapid point-of-care CYP2C19*2 genotyping to personalise antiplatelet therapy in patients undergoing coronary stenting | Wirth, Francesca; Xuereb, Robert G.; Fenech, Albert; Azzopardi, Lilian M. |
2018 | Relationship of hyperglycaemia, hypoglycaemia, and glucose variability to atherosclerotic disease in type 2 diabetes | Magri, Caroline Jane; Mintoff, Dillon; Camilleri, Liberato; Xuereb, Robert G.; Galea, Joseph; Fava, Stephen |
2016-10 | Retrospective analysis of serum digoxin concentrations at Mater Dei Hospital | Vella, John; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Zarb Adami, Maurice; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2016-10 | Safer anticoagulation management in the community : a pharmacist-led approach | Mifsud, Elena Marie; Wirth, Francesca; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony; Azzopardi, Lilian M. |
2022 | Six months after the patients stayed home : a nationwide study of cardiac mortality and readmissions following the first wave of the COVID-19 pandemic in Malta | Grech, Neil; Xuereb, Rachel A.; Xuereb, Robert G.; Caruana, Maryanne |
2018-09 | SLCO1B1 genetic polymorphisms in cardiac patients on simvastatin | Cerdá Iñesta, Judith; Wirth, Francesca; Zahra, Graziella; Xuereb, Robert G.; Barbara, Christopher; Serracino-Inglott, Anthony |
2014 | Smoking ban : a long-term analysis of the Malta paradox in a population of over 400,000 subjects | Xuereb, Robert G.; Distefano, Sandra; Magri, Caroline Jane; Calleja, Neville; Grech, Victor E. |
2020 | Smoking cessation in post-hospitalisation cardiac rehabilitation | Scicluna, Gabrielle; Gauci, Marilyn; Xuereb, Clifford; Desira, Josette; Xuereb, Robert G.; Wirth, Francesca; Azzopardi, Lilian M. |
2008 | Transcatheter device closure of atrial septal defect and patent foramen ovale in Malta | Grech, Victor E.; Aquilina, Oscar; Felice, Herbert; Fenech, Albert; Xuereb, Robert G.; Xuereb, Mariosa; Tilney, Terrence; Aquilina, Josanne; Vella, Norbert; Galea Debono, Anthony; DeGiovanni, Joseph V. |
2009 | ‘Twiddling’ of the pacemaker resulting in lead dislodgement | Cassar DeMarco, Daniela; Xuereb, Robert G. |
2022 | When the patients stayed home : the impact of the COVID-19 pandemic on acute cardiac admissions and cardiac mortality in Malta | Grech, Neil; Xuereb, Rachel; England, Kathleen; Xuereb, Robert G.; Caruana, Maryanne |